Innovative cell therapy

Glycostem Therapeutics B.V. is a Dutch life science company that develops cellular immune therapies for the treatment of leukemia and other forms of cancer. The company has developed a new and innovative GMP cell production system, with which large amounts of active and very pure Natural Killer (NK) cells from umbilical cord blood can be produced. The first NK cell product has now been clinically tested and the results are very promising.

For further information see: www.glycostem.com